CD4-CD8-αβ and γδ T Cells Display Inflammatory and Regulatory Potentials during Human Tuberculosis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Pinheiro, Melina B ^a   Antonelli, Lis R ^b   Sathler Avelar, Renato ^b   Vitelli Avelar, Danielle M ^b   Spindola de Miranda, Silvana ^a   Guimarães, Tânia M P D ^a   Teixeira Carvalho, Andrea ^b   Martins Filho, Olindo A ^b   Toledo, Vicente P C P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ADULT; AGED; ALPHA BETA DOUBLE NEGATIVE T LYMPHOCYTE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LUNG TUBERCULOSIS; MALE; NONHUMAN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84871149324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050923     Document Type: Article

References (42)

1. Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, et al. (2005) Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood 105: 2828-2835.
2. Liu MF, Yang CY, Chao SC, Li JS, Weng TH, et al. (1999) Distribution of double-negative (CD4- CD8-, DN) T subsets in blood and synovial fluid from patients with rheumatoid arthritis. Clin Rheumatol 18: 227-231.
3. Sieling PA, Porcelli SA, Duong BT, Spada F, Bloom BR, et al. (2000) Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol 165: 5338-5344.
4. Thomson CW, Lee BP, Zhang L, (2006) Double-negative regulatory T cells: non-conventional regulators. Immunol Res 35: 163-178.
5. Liu MF, Li JS, Weng TH, Lei HY, (1998) Double-negative (CD4-CD8-) TCRalphabeta+ cells in patients with systemic lupus erythematosus. Scand J Rheumatol 27: 130-134.
6. Villani FN, Rocha MO, Nunes Mdo C, Antonelli LR, Magalhaes LM, et al. (2010) Trypanosoma cruzi-induced activation of functionally distinct alphabeta and gammadelta CD4- CD8- T cells in individuals with polar forms of Chagas' disease. Infect Immun 78: 4421-4430.
7. Antonelli LR, Dutra WO, Oliveira RR, Torres KC, Guimaraes LH, et al. (2006) Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. Infect Immun 74: 6317-6323.
8. Derrick SC, Evering TH, Sambandamurthy VK, Jalapathy KV, Hsu T, et al. (2007) Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine. Immunology 120: 192-206.
9. Thomssen H, Ivanyi J, Espitia C, Arya A, Londei M, (1995) Human CD4-CD8- alpha beta + T-cell receptor T cells recognize different mycobacteria strains in the context of CD1b. Immunology 85: 33-40.
10. Janis EM, Kaufmann SH, Schwartz RH, Pardoll DM, (1989) Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science 244: 713-716.
11. Casetti R, Martino A, (2008) The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy. Cell Mol Immunol 5: 161-170.
12. Gioia C, Agrati C, Goletti D, Vincenti D, Carrara S, et al. (2003) Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int J Immunopathol Pharmacol 16: 247-252.
13. Flynn JL, Chan J, (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93-129.
14. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, et al. (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150: 353-360.
15. Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, et al. (1996) Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med 183: 2559-2569.
16. Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, et al. (2006) NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol 177: 7086-7093.
17. Al-Moamary MS, Black W, Bessuille E, Elwood RK, Vedal S, (1999) The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest 116: 726-731.
18. Lazzarini LC, Spindola SM, Bang H, Gibson AL, Weisenberg S, et al. (2008) RDRio Mycobacterium tuberculosis infection is associated with a higher frequency of cavitary pulmonary disease. J Clin Microbiol 46: 2175-2183.
19. Dellabona P, Casorati G, Friedli B, Angman L, Sallusto F, et al. (1993) In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset. J Exp Med 177: 1763-1771.
20. Porcelli S, Morita CT, Brenner MB, (1992) CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen. Nature 360: 593-597.
21. Barnes PF, Grisso CL, Abrams JS, Band H, Rea TH, et al. (1992) Gamma delta T lymphocytes in human tuberculosis. J Infect Dis 165: 506-512.
22. Stenger S, Mazzaccaro RJ, Uyemura K, Cho S, Barnes PF, et al. (1997) Differential effects of cytolytic T cell subsets on intracellular infection. Science 276: 1684-1687.
23. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A, (2011) Immunological biomarkers of tuberculosis. Nat Rev Immunol 11: 343-354.
24. Montoya CJ, Catano JC, Ramirez Z, Rugeles MT, Wilson SB, et al. (2008) Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol 127: 1-6.
25. Ottenhoff TH, Verreck FA, Hoeve MA, van de Vosse E, (2005) Control of human host immunity to mycobacteria. Tuberculosis (Edinb) 85: 53-64.
26. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R, (2009) Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 23: 1717-1725.
27. Streitz M, Fuhrmann S, Powell F, Quassem A, Nomura L, et al. (2011) Tuberculin-specific T cells are reduced in active pulmonary tuberculosis compared to LTBI or status post BCG vaccination. J Infect Dis 203: 378-382.
28. Almeida AS, Lago PM, Boechat N, Huard RC, Lazzarini LC, et al. (2009) Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J Immunol 183: 718-731.
29. Bruns H, Meinken C, Schauenberg P, Harter G, Kern P, et al. (2009) Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 119: 1167-1177.
30. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, et al. (1995) Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572.
31. Adams LB, Mason CM, Kolls JK, Scollard D, Krahenbuhl JL, et al. (1995) Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. J Infect Dis 171: 400-405.
32. Botha T, Ryffel B, (2003) Reactivation of latent tuberculosis infection in TNF-deficient mice. J Immunol 171: 3110-3118.
33. Byrd TF, (1997) Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes. J Clin Invest 99: 2518-2529.
34. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098-1104.
35. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48: 2122-2127.
36. Sai Priya VH, Latha GS, Hasnain SE, Murthy KJ, Valluri VL, (2010) Enhanced T cell responsiveness to Mycobacterium bovis BCG r32-kDa Ag correlates with successful anti-tuberculosis treatment in humans. Cytokine 52: 190-193.
37. O'Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C, (2008) Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 223: 114-131.
38. Jankovic D, Trinchieri G, (2007) IL-10 or not IL-10: that is the question. Nat Immunol 8: 1281-1283.
39. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, et al. (2000) IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105: 1317-1325.
40. Gong JH, Zhang M, Modlin RL, Linsley PS, Iyer D, et al. (1996) Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 64: 913-918.
41. Redford PS, Boonstra A, Read S, Pitt J, Graham C, et al. (2010) Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol 40: 2200-2210.
42. Ueta C, Tsuyuguchi I, Kawasumi H, Takashima T, Toba H, et al. (1994) Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients. Infect Immun 62: 5434-5441.